Security Snapshot

Co-Diagnostics, Inc. - Common Stock, par value $0.001 per share (CODX) Institutional Ownership

CUSIP: 189763204

13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

24

Shares (Excl. Options)

595,808

Price

$3.10

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+546,599
Value change
+$1,694,873
Number of holders
24
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
5,602,663
SEC-reported price per share
$1.49
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CODX - Co-Diagnostics, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 189763204.
  • 24 institutions reported positions in Q2 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 14 to 24 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $91,501 to $1,847,391.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 24 institutions filings for Q2 2026.

Open SEC evidence

Security key

189763204

Latest holder period

Q2 2026

13F holders

24

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
CODX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% $1,460,833 559,706 Armistice Capital, LLC 30 Jun 2026
JANE STREET GROUP, LLC 1.7% -78% $232,916 -$383,981 89,240 -62% JANE STREET GROUP, LLC 30 Jun 2026

As of 30 Jun 2026, 24 institutional investors reported holding 595,808 shares of Co-Diagnostics, Inc. - Common Stock, par value $0.001 per share (CODX). This represents 11% of the company’s total 5,602,663 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
11%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 4.2% 236,000 0.02% $731,600
JANE STREET GROUP, LLC 1.6% 89,240 0% $276,644
VANGUARD CAPITAL MANAGEMENT LLC 1% 58,275 0% $180,653
Private Advisory Group LLC 0.7% 39,387 -4.8% 0.01% $122,100
MILLENNIUM MANAGEMENT LLC 0.57% 31,995 0% $99,184
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.56% 31,239 0% $96,841
GEODE CAPITAL MANAGEMENT, LLC 0.46% 25,575 0% $79,282
VANGUARD FIDUCIARY TRUST CO 0.35% 19,776 +1977500% 0% $61,306
Virtu Financial LLC 0.31% 17,612 0% $55,000
UBS Group AG 0.29% 16,091 +118% 0% $49,882
STATE STREET CORP 0.26% 14,800 0% $45,880
RENAISSANCE TECHNOLOGIES LLC 0.22% 12,500 0% $38,750
MORGAN STANLEY 0.05% 2,877 +3169% 0% $8,919
Smartleaf Asset Management LLC 0% 133 0% 0% $396
Global Retirement Partners, LLC 0% 100 0% $310
SBI Securities Co., Ltd. 0% 81 +40% 0% $251
WELLS FARGO & COMPANY/MN 0% 81 0% 0% $251
Heritage Wealth Advisors 0% 17 0% 0% $53
OSAIC HOLDINGS, INC. 0% 10 0% 0% $31
FMR LLC 0% 7 0% $21
NewEdge Advisors, LLC 0% 6 0% 0% $19
JPMORGAN CHASE & CO 0% 3 -94% 0% $9
HARBOUR INVESTMENTS, INC. 0% 2 0% 0% $6
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0% 1 0% $3
DANSKE BANK A/S 0% 0 -100% $0

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
3
Latest
Q2 2026
Rows shown
1-3 of 3
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 595,808 $1,847,391 +$1,694,873 $3.10 24
2026 Q1 49,209 $91,501 +$87,910 $1.86 14
2025 Q4 1,922 $325 +$325 $0.17 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .